Hypoxia Clinical Trial
Official title:
Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α. A Pilot Proof of Principle Study
Oxygen is a widely available gas that is cheap, easy to get and extensively used in medicine. From animal studies it has become apparent that increasing or lowering the degree of oxygen in the blood, the inflammatory response can be altered. We will investigate of this is also true in humans by increasing, lowering or keeping oxygen levels normal while giving healthy subjects a short inflammatory stimulus.
The primary objective of the study is to determine the effects of hyperoxia and hypoxia
compared to normoxia in the human endotoxemia model on the innate immune reponse in healthy
volunteers.
A parallel, randomized study in healthy male volunteers. The subjects will be randomized to
hypoxia, hyperoxia, or normoxia, and will all undergo experimental human endotoxemia
(administration of 2 ng/kg LPS iv).
In the hypoxia group: the subjects will breathe an individualized mix of nitrogen and room
air for 3.5 hours using an air-tight respiratory helmet. The gas mixture will be adjusted to
achieve a saturation of 80-85%. In the hyperoxia group, subjects will breathe 100% oxygen
for 3.5 hours using the same respiratory helmet. In the normoxia group, subjects will
breathe room air (21% oxygen, 79% nitrogen) also wearing the respiratory helmet. 1 hour
after oxygen status adjustment (t=0), all subject will be administered an intravenous bolus
(2ng/kg) of LPS derived from E coli O:113. 2.5 hours after LPS administration, the helmets
will be removed and all subjects will breathe ambient room air.
The primary study endpoint is the difference in plasma cytokines between the hypoxia and
normoxia group, and between the hyperoxia and normoxia group. Secondary objectives include
HIF-1α protein and mRNA, aHIF mRNA expression in circulating leukocytes, measures of ROS,
leukocyte phagocytosis, and cytokine production by leukocytes stimulated ex vivo with
various inflammatory stimuli, and measurement of basic hemodynamic and ventilatory
parameters and temperature.
;
Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04498598 -
Structural Modification In Supraglottic Airway Device
|
N/A | |
Completed |
NCT05532670 -
N600X Low Saturation Accuracy Validation
|
||
Enrolling by invitation |
NCT04106401 -
Intravascular Volumes in Hypoxia During Antarctic Confinement
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Not yet recruiting |
NCT05817448 -
Hypoxia-induced Autophagy in the Pathogenesis of MAP
|
||
Recruiting |
NCT02661152 -
DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.
|
Phase 3 | |
Terminated |
NCT02801162 -
Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard
|
N/A | |
Not yet recruiting |
NCT02201875 -
Intrinsic Periodic Pattern of Breathing
|
N/A | |
Completed |
NCT02943863 -
Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia
|
N/A | |
Completed |
NCT01922401 -
Inverse Ratio Ventilation on Bariatric Operation
|
N/A | |
Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
Active, not recruiting |
NCT01681238 -
Goal-directed Therapy in High-risk Surgery
|
N/A | |
Completed |
NCT01463527 -
Using Capnography to Reduce Hypoxia During Pediatric Sedation
|
N/A | |
Completed |
NCT01507623 -
Value of Capnography During Nurse Administered Propofol Sedation (NAPS)
|
N/A | |
Withdrawn |
NCT00638040 -
The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression
|
N/A | |
Active, not recruiting |
NCT06097754 -
Intermittent Exogenous Ketosis (IEK) at High Altitude
|
N/A | |
Completed |
NCT04589923 -
The VISION-Acute Study
|
||
Completed |
NCT05044585 -
Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers
|
N/A | |
Completed |
NCT03659513 -
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
|
||
Completed |
NCT03221387 -
Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients
|
N/A |